# Health Catalyst to Participate in Upcoming Investor Conferences
Canonical URL: https://biopharmsignal.com/news/HCAT/health-catalyst-to-participate-in-upcoming-investor-conferences-8907e462
Ticker: HCAT
Company: Health Catalyst
Source: Health Catalyst
Published: 2025-11-14 21:14 EST
## Summary

Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics...

## Article Body
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:

The Stephens Annual Investment Conference, being held in Nashville, including a fireside chat with Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, November 19, 2025 at 3:00pm CT.

The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, being held in New York, including 1x1 meeting opportunities with Dan Burton, Chief Executive Officer, Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Thursday, November 20, 2025.

The 8th Annual Evercore Healthcare Conference, being held in Miami, including a fireside chat with Dan Burton, Chief Executive Officer, Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Tuesday, December 2, 2025 at 8:20am ET.

The Citi’s 2025 Global Healthcare Conference, being held in Miami, including 1x1 meeting opportunities with Dan Burton, Chief Executive Officer, Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, December 3, 2025.

About Health Catalyst Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,100 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.

Media Contact: Kathryn Mykleseth Director of PR and Communications media@healthcatalyst.com

Investor Relations Contact: Matt Hopper SVP of Finance and Head of Investor Relations ir@healthcatalyst.com
## Recent Company News
- 2026-06-16 20:05 EST — [Health Catalyst to Participate in Upcoming Investor Conference](https://biopharmsignal.com/news/HCAT/health-catalyst-to-participate-in-upcoming-investor-conference-70ce0f58) — Source: Health Catalyst
- 2026-06-04 13:03 EST — [Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation](https://biopharmsignal.com/news/HCAT/health-catalyst-to-divest-vitalware-for-147-million-accelerating-strategic-trans-3fdcad3f) — Source: Health Catalyst
- 2026-05-11 20:05 EST — [Health Catalyst Reports First Quarter 2026 Results](https://biopharmsignal.com/news/HCAT/health-catalyst-reports-first-quarter-2026-results-bc27d6b4) — Source: Health Catalyst
- 2026-05-01 12:00 EST — [Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026](https://biopharmsignal.com/news/HCAT/health-catalyst-to-announce-first-quarter-2026-operating-results-and-host-confer-a23ecc29) — Source: Health Catalyst
- 2026-04-30 13:27 EST — [Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors](https://biopharmsignal.com/news/HCAT/health-catalyst-appoints-steve-nelson-president-of-aetna-to-its-board-of-directo-59637695) — Source: Health Catalyst
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)